Skip to main content

Advertisement

Log in

Analysis of Characteristics Similar to Autoimmune Disease in Keloid Patients

  • Original Article
  • Experimental/Special Topics
  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

Keloid is a fibrotic skin disease for which immune cell infiltration is a primary pathological hallmark. Meanwhile, in autoimmune diseases, triggering of the inflammation response can lead to tissue injury and subsequent organ fibrosis. When the skin is involved in autoimmune disease, skin fibrosis such as that seen in scleroderma can occur. In this study, we propose that keloid possesses features of autoimmune disease.

Methods

To verify whether keloid possesses features of autoimmune disease, immune cell infiltration and immune complex deposits were detected with immunohistochemical staining and immunofluorescence, respectively, in keloid and normal skin tissues. A routine antinuclear antibody profile was tested in sera from 28 keloid patients and 28 healthy controls. Lastly, the anti-hnRNPA2B1 autoantibody in sera was evaluated by enzyme-linked immunosorbent assay.

Results

The numbers of CD1α+ Langerhans cells, CD3+ T lymphocytes, CD68+ macrophages, and CD20+ B lymphocytes increased in keloid tissues compared to normal skin. IgA, IgM, C3, and C1q deposits were found in keloid tissues but not in normal skin, while anti-hnRNPA2B1 levels in sera from keloid patients were elevated.

Conclusion

The above findings suggest that keloids have some characteristics that are similar to autoimmune disease and might be mediated by autoimmune responses.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H (2009) Keloids: current concepts of pathogenesis (review). Int J Mol Med 24:283–293

    Article  CAS  PubMed  Google Scholar 

  2. Bayat A, McGrouther DA, Ferguson MW (2003) Skin scarring. BMJ 326:88–92

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61:1049–1058

    Article  CAS  PubMed  Google Scholar 

  4. Bagabir R, Byers RJ, Chaudhry IH, Muller W, Paus R, Bayat A (2012) Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. Br J Dermatol 167:1053–1066

    Article  CAS  PubMed  Google Scholar 

  5. Verhaegen PD, van Zuijlen PP, Pennings NM, van Marle J, Niessen FB, van der Horst CM, Middelkoop E (2009) Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen 17:649–656

    Article  PubMed  Google Scholar 

  6. Kisseleva T, Brenner DA (2008) Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233:109–122

    Article  CAS  Google Scholar 

  7. Stramer BM, Mori R, Martin P (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127:1009–1017

    Article  CAS  PubMed  Google Scholar 

  8. Detlefsen S, Brasen JH, Zamboni G, Capelli P, Kloppel G (2010) Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology 57:825–835

    Article  PubMed  Google Scholar 

  9. Peterson LS, Nelson AM, Su WP (1995) Classification of morphea (localized scleroderma). Mayo Clin Proc 70:1068–1076

    Article  CAS  PubMed  Google Scholar 

  10. Denton CP, Black CM, Abraham DJ (2006) Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2:134–144

    Article  PubMed  Google Scholar 

  11. Butler PD, Longaker MT, Yang GP (2008) Current progress in keloid research and treatment. J Am Coll Surg 206:731–741

    Article  PubMed  Google Scholar 

  12. Huo AP, Lin KC, Chou CT (2010) Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren’s syndrome. Int J Rheum Dis 13:39–47

    Article  PubMed  Google Scholar 

  13. De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F (2005) The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 14:931–937

    Article  PubMed  Google Scholar 

  14. Marin GG, Cardiel MH, Cornejo H, Viveros ME (2009) Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol 15:325–329

    Article  PubMed  Google Scholar 

  15. Pisetsky DS (2011) Antinuclear antibodies in healthy people: the tip of autoimmunity’s iceberg? Arthritis Res Ther 13:109

    Article  PubMed Central  PubMed  Google Scholar 

  16. Mayadas TN, Tsokos GC, Tsuboi N (2009) Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation 120:2012–2024

    Article  PubMed Central  PubMed  Google Scholar 

  17. McCarty SM, Syed F, Bayat A (2010) Influence of the human leukocyte antigen complex on the development of cutaneous fibrosis: an immunogenetic perspective. Acta Derm Venereol 90:563–574

    Article  CAS  PubMed  Google Scholar 

  18. Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301:259–272

    Article  PubMed  Google Scholar 

  19. Kazeem AA (1988) The immunological aspects of keloid tumor formation. J Surg Oncol 38:16–18

    Article  CAS  PubMed  Google Scholar 

  20. Bloch EF, Hall MG Jr, Denson MJ, Slay-Solomon V (1984) General immune reactivity in keloid patients. Plast Reconstr Surg 73:448–451

    Article  CAS  PubMed  Google Scholar 

  21. Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RF (1979) Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 63:689–695

    Article  CAS  PubMed  Google Scholar 

  22. Kischer CW, Shetlar MR, Shetlar CL, Chvapil M (1983) Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 71:821–825

    Article  CAS  PubMed  Google Scholar 

  23. Yagi KI, Dafalla AA, Osman AA (1979) Does an immune reaction to sebum in wounds cause keloid scars? Beneficial effect of desensitisation. Br J Plast Surg 32:223–225

    Article  CAS  PubMed  Google Scholar 

  24. Janssen de Limpens AM, Cormane RH (1982) Keloids and hypertrophic scars–immunological aspects. Aesthetic Plast Surg 6:149–152

    Article  CAS  PubMed  Google Scholar 

  25. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG (1993) hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62:289–321

    Article  CAS  PubMed  Google Scholar 

  26. Caporali R, Bugatti S, Bruschi E, Cavagna L, Montecucco C (2005) Autoantibodies to heterogeneous nuclear ribonucleoproteins. Autoimmunity 38:25–32

    Article  CAS  PubMed  Google Scholar 

  27. Dangli A, Guialis A, Vretou E, Sekeris CE (1988) Autoantibodies to the core proteins of hnRNPs. FEBS Lett 231:118–124

    Article  CAS  PubMed  Google Scholar 

  28. Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, Thumb N, Smolen JS (1989) Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 32:1515–1520

    Article  CAS  PubMed  Google Scholar 

  29. Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A (2007) Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen. Autoimmunity 40:223–233

    Article  CAS  PubMed  Google Scholar 

  30. Neri R, Tavoni A, Cristofani R, Levanti C, Sodini G, d’Ascanio A, Vitali C, Ferri C, Bombardieri S (1992) Antinuclear antibody profile in Italian patients with connective tissue diseases. Lupus 1:221–227

    Article  CAS  PubMed  Google Scholar 

  31. Guevara-Gutierrez E, Yinh-Lao J, Garcia-Gutierrez P, Tlacuilo-Parra A (2010) Frequency of antinuclear antibodies in mestizo Mexican children with morphea. Clin Rheumatol 29:1055–1059

    Article  PubMed  Google Scholar 

  32. Preisz K, Sardy M, Horvath A, Karpati S (2005) Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol 19:74–79

    Article  CAS  PubMed  Google Scholar 

  33. Shaker SA, Ayuob NN, Hajrah NH (2011) Cell talk: a phenomenon observed in the keloid scar by immunohistochemical study. Appl Immunohistochem Mol Morphol 19:153–159

    Article  PubMed  Google Scholar 

  34. Onodera M, Ueno M, Ito O, Suzuki S, Igawa HH, Sakamoto H (2007) Factor XIIIa-positive dermal dendritic cells in keloids and hypertrophic and mature scars. Pathol Int 57:337–342

    Article  PubMed  Google Scholar 

  35. Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG (2001) Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg 54:511–516

    Article  CAS  PubMed  Google Scholar 

  36. Lim PL, Zouali M (2006) Pathogenic autoantibodies: emerging insights into tissue injury. Immunol Lett 103:17–26

    Article  CAS  PubMed  Google Scholar 

  37. Benoist C, Mathis D (2000) A revival of the B cell paradigm for rheumatoid arthritis pathogenesis? Arthritis Res 2:90–94

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Leandro MJ (2013) B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies. Arthritis Res Ther 15(Suppl 1):S3

    Article  PubMed Central  PubMed  Google Scholar 

  39. Bluml S, McKeever K, Ettinger R, Smolen J, Herbst R (2013) B-cell targeted therapeutics in clinical development. Arthritis Res Ther 15(Suppl 1):S4

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by National Natural Science Foundation of China (30871433, 31071305).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ran Xiao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiao, H., Fan, J., Cai, J. et al. Analysis of Characteristics Similar to Autoimmune Disease in Keloid Patients. Aesth Plast Surg 39, 818–825 (2015). https://doi.org/10.1007/s00266-015-0542-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-015-0542-4

Keywords

Navigation